Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study

被引：0

作者：

Andreas Hochhaus

Michele Baccarani

Francis J. Giles

Philipp D. le Coutre

Martin C. Müller

Andreas Reiter

Helene Santanastasio

Mimi Leung

Steven Novick

Hagop M. Kantarjian

机构：

[1] Universitätsklinikum Jena,Abteilung für Hämatologie und Internistische Onkologie

[2] University of Bologna,Medizinische Universitätsklinik

[3] Northwestern Medicine Developmental Therapeutics Institute,undefined

[4] Charité - University of Medicine Berlin,undefined

[5] Medizinische Fakultät Mannheim der Universität Heidelberg,undefined

[6] Novartis Pharmaceuticals Corporation,undefined

[7] The University of Texas,undefined

[8] MD Anderson Cancer Center,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2015年 / 141卷

关键词：

Nilotinib; Tyrosine kinase inhibitor; Systemic mastocytosis; KIT D816V; Aggressive systemic mastocytosis; Indolent systemic mastocytosis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2047 / 2060

页数：13

共 50 条

[1] Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study
Hochhaus, Andreas
Baccarani, Michele
Giles, Francis J.
Le Coutre, Philipp D.
Mueller, Martin C.
Reiter, Andreas
Santanastasio, Helene
Leung, Mimi
Novick, Steven
Kantarjian, Hagop M.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (11) : 2047 - 2060
[2] Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
Gelderblom, Hans
Cropet, Claire
Chevreau, Christine
Boyle, Richard
Tattersall, Martin
Stacchiotti, Silvia
Italiano, Antoine
Piperno-Neumann, Sophie
Le Cesne, Axel
Ferraresi, Virginia
Penel, Nicolas
Duffaud, Florence
Cassier, Philippe
Toulmonde, Maud
Casali, Paolo
Taieb, Sophie
Guillemaut, Severine
Metzger, Severine
Perol, David
Blay, Jean-Yves
LANCET ONCOLOGY, 2018, 19 (05): : 639 - 648
[3] Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 study
Hochhaus, Andreas
le Coutre, Philipp D.
Kantarjian, Hagop M.
Baccarani, Michele
Erben, Philipp
Reiter, Andreas
McCulloch, Tracey
Fan, Xiaolin
Novick, Steven
Giles, Francis J.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (12) : 1985 - 1993
[4] Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 study
Andreas Hochhaus
Philipp D. le Coutre
Hagop M. Kantarjian
Michele Baccarani
Philipp Erben
Andreas Reiter
Tracey McCulloch
Xiaolin Fan
Steven Novick
Francis J. Giles
Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1985 - 1993
[5] Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study
Harari, Sergio
Elia, Davide
Caminati, Antonella
Geginat, Jens
Luisi, Francesca
Pelosi, Giuseppe
Specchia, Claudia
Torre, Olga
Trevisan, Roberta
Vasco, Chiara
Zompatori, Maurizio
Cassandro, Roberto
LANCET RESPIRATORY MEDICINE, 2024, 12 (12): : 967 - 974
[6] EFFICACY AND SAFETY OF AVAPRITINIB IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS: INTERIM RESULTS FROM THE OPEN-LABEL, SINGLE-ARM, PHASE 2 PATHFINDER STUDY
Vannucchi, A. M.
DeAngelo, D. J.
Reiter, A.
Radia, D.
Deininger, M. W.
George, T. I.
Panse, J.
Jentzsch, M.
Alvarez-Twose, I.
Mital, A.
Hermine, O.
Dybedal, I.
Hexner, E. O.
Hicks, L. K.
Span, L.
Mesa, R.
Bose, P.
Pettit, K. M.
Heaney, M. L.
Oh, S.
Sen, J.
Lin, H-M.
Mar, B. G.
Gotlib, J.
HAEMATOLOGICA, 2021, 106 (10) : 2 - 2
[7] Efficacy of Avapritinib in Patients with Advanced Systemic Mastocytosis: Hematologic and Bone Marrow Responses from the Phase 2 Open-Label, Single-Arm, Pathfinder Study
George, Tracy I.
Karner, Kristin H.
Moser, Karen A.
Rets, Anton
Fredericks, Michelle
Reiter, Andreas
Radia, Deepti H.
Deininger, Michael W.
Lin, Hui-Min
Sen, Jayita
Gotlib, Jason
Dimitrijevic, Sasa
Deangelo, Daniel J.
BLOOD, 2021, 138
[8] Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma
Schwartzberg, Lee
Hermann, Robert
Flinn, Ian
Flora, Douglas
Hsi, Eric D.
Hamid, Oday
Shi, Peipei
Lin, Boris K.
Myrand, Scott P.
Nguyen, Tuan S.
Dreyling, Martin
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (01) : 91 - 97
[9] Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
Brastianos, Priscilla K.
Lee, Eudocia Quant
Cohen, Justine V.
Tolaney, Sara M.
Lin, Nancy U.
Wang, Nancy
Chukwueke, Ugonma
White, Michael D.
Nayyar, Naema
Kim, Albert
Alvarez-Breckenridge, Christopher
Krop, Ian
Mahar, Maura Keeley
Bertalan, Mia S.
Shaw, Brian
Mora, Joana L.
Goss, Nathaniel
Subramanian, Megha
Nayak, Lakshmi
Dietrich, Jorg
Forst, Deborah A.
Nahed, Brian V.
Batchelor, Tracy T.
Shih, Helen A.
Gerstner, Elizabeth R.
Moy, Beverly
Lawrence, Donald
Giobbie-Hurder, Anita
Carter, Scott L.
Oh, Kevin
Cahill, Daniel P.
Sullivan, Ryan J.
NATURE MEDICINE, 2020, 26 (08) : 1280 - +
[10] An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
Agulnik, Mark
Schulte, Brian
Robinson, Steven
Hirbe, Angela C.
Kozak, Kevin
Chawla, Sant P.
Attia, Steven
Rademaker, Alfred
Zhang, Hui
Abbinanti, Susan
Cehic, Rasima
Monga, Varun
Milhem, Mohammed
Okuno, Scott
Van Tine, Brian A.
EUROPEAN JOURNAL OF CANCER, 2021, 154 : 201 - 208

← 1 2 3 4 5 →